International Edition
Latest News
Health

Enanta Pharmaceuticals Q1 Earnings: Snapshot Analysis

Enanta Pharmaceuticals Inc. (ENTA) on Monday reported a loss of $11.9 million in its fiscal first quarter. WATERTOWN, Mass.(AP) — WATERTOWN, Mass. (AP) — Enanta Pharmaceuticals Inc. (ENTA) on Monday reported a loss of $11.9 million in its…

By Dr Natalie Singh - Health Editor
Enanta Pharmaceuticals Q1 Earnings: Snapshot Analysis

Enanta Pharmaceuticals Inc. (ENTA) on Monday reported a loss of $11.9 million in its fiscal first quarter.

WATERTOWN, Mass.(AP) — WATERTOWN, Mass. (AP) — Enanta Pharmaceuticals Inc. (ENTA) on Monday reported a loss of $11.9 million in its fiscal first quarter.

On a per-share basis, the Watertown, Massachusetts-based company said it had a loss of 42 cents.

The biotechnology company posted revenue of $18.6 million in the period.

This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on ENTA at

Copyright 2025 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.


For contact, advertising, copyright, issues email: office@archynewsy.com

date: 2026-02-09 21:28:00

Worth a look

About the author: Dr Natalie Singh - Health Editor

Board‑certified internal‑medicine physician and MPH. Natalie authored peer‑reviewed studies on infectious disease and served as medical editor. “Dr. Natalie Singh delivers evidence‑based health news, medical breakthroughs, and expert wellness guidance.”

Archynewsy